MoonLake Immunotherapeutics (MLTX) Q1 2025 Earnings

Feb 26Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.72
-0.54
-0.37
-0.19

Details

Expected EPS
-0.620269
Actual EPS
-0.72
Surprise EPS
-0.1
Surprise Percent
-16.08%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-0.72⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts